Top Story

Maintenance pazopanib extended PFS, not OS in ovarian cancer

October 24, 2014

Maintenance therapy with pazopanib extended PFS by about 45% among women with ovarian cancer whose disease did not progress during first-line chemotherapy, according to results of a phase 3 study.

However, the maintenance regimen did not appear to confer an OS benefit.

figure Meeting News CoverageVideo

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he participated in at the Cardiometabolic Health…
figure Meeting News CoverageVideo

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed primarily at diabetes or metabolic disease poses…
figure Meeting News Coverage

Efficacy, safety of aspirin for treatment of patients with diabetes, CAD unclear

October 24, 2014
BOSTON — The benefits of using aspirin, alone or with a platelet inhibitor, for the treatment of patients with diabetes at high-risk for CVD are still unclear…
More News Headlines »
CME
figure

OCT in the Management of Macular Degeneration

This activity is supported by an educational grant from Carl Zeiss Meditec.

Advances in retinal pharmacology have significantly improved outcomes for patients with a range of chronic retinal…
More »
Editorial

Fostering Student Accountability for Learning

Journal of Nursing Education, October 2014, Volume 53 Issue 10
No abstract is available for this article.
More »
Meeting News Coverage Video
figure

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he…
More »